USPTO serial 79339458
I PEACE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 15, 2023
- Examiner
- CANTONE, KERI H
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with I PEACE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cell culture media for laboratory use, other than for medical or veterinary purposes; microorganism culture media for laboratory use, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; chemicals used as ingredients for manufacture of cosmetics; chemicals for industrial purposes; culture fluid for human stem cell as an ingredient for cosmetics manufacturing; stem cells for research and scientific purposes; cell culture media for scientific or research purposes | ACTIVE | — |
| 003 | Cosmetics containing culture fluid for human stem cell; cosmetics; bath and cosmetic soaps and laundry and dishwasher detergents; dentifrices; perfumery | ACTIVE | — |
| 005 | Stem cells for medical purposes; stem cells for clinical medical purposes; stem cells for veterinary purposes; diagnostic media for bacteriological cultures; cell culture media for microorganism culture for medical use; cell culture for medical use; pharmaceutical preparations for human use derived from iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; pharmaceutical preparations for human use developed by using iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; dietary supplements; dietetic preparations adapted for medical purposes | ACTIVE | — |
| 039 | Storage of stem cell and cells; warehousing services for deposited frozen stem cell and cells; consultancy and information relating to warehousing services for deposited frozen stem cell and cells; warehousing services | ACTIVE | — |
| 042 | Cell culture services for scientific and research purposes for others; providing scientific information related to cell culture; cytogenetic examination being cytogenic research services for others; testing examination, research and development in the field of regenerative medicine; testing, examination, research and development in the field of cytology; testing, examination, research and development of cosmetics; medical laboratory services; research in the field of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; conducting clinical trials for pharmaceuticals | ACTIVE | — |
| 044 | Stem cell bank services; medical treatment services by using cultured cells; stem cell therapy services; collection and preservation of stem cells for use in regenerative medicine; collection and preservation of human blood; providing medical information in the field of cells; providing medical information related to regenerative medicine; provision of medical information; medical treatment and diagnosis services by using cultured cells for medical and clinical purposes; medical services; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis by regenerative medicine; medical treatment and diagnosis services by cell therapy; medical treatment and consulting services by cell preparations; medical treatment of speech disorders, breast cancer and infertility, neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease, not limited to stem cells; preservation of human blood as a supply source of stem cells; clinical medical examination; evaluation of clinical examination for medical purposes; genetic testing for medical purposes; providing medical facilities; Health clinic services; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by I Peace, Inc.
- Other trademarks owned by I Peace, Inc.
- Other trademarks owned by I Peace, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named I PEACE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 28, 2024 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jan 1, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 11, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 16, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 15, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 15, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 15, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 15, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 30, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 10, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 25, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 9, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 9, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 9, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 27, 2022 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Dec 27, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 17, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 26, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 26, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 28, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 27, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 17, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 13, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 10, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 28, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |